216 related articles for article (PubMed ID: 11469343)
1. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
Shiratsuchi H; Oshiro Y; Saito T; Itakura E; Kinoshita Y; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
Int J Surg Pathol; 2001 Jan; 9(1):37-48. PubMed ID: 11469343
[TBL] [Abstract][Full Text] [Related]
2. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
Oda Y; Tsuneyoshi M
Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
[TBL] [Abstract][Full Text] [Related]
3. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor.
Saito T; Oda Y; Itakura E; Shiratsuchi H; Kinoshita Y; Oshiro Y; Tamiya S; Hachitanda Y; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2001 Jul; 51(7):532-42. PubMed ID: 11472566
[TBL] [Abstract][Full Text] [Related]
4. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
Guillou L; Wadden C; Coindre JM; Krausz T; Fletcher CD
Am J Surg Pathol; 1997 Feb; 21(2):130-46. PubMed ID: 9042279
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis.
Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation.
Shiratsuchi H; Saito T; Sakamoto A; Itakura E; Tamiya S; Oshiro Y; Oda Y; Toh S; Komiyama S; Tsuneyoshi M
Mod Pathol; 2002 Feb; 15(2):146-53. PubMed ID: 11850543
[TBL] [Abstract][Full Text] [Related]
9. Soft-tissue extrarenal rhabdoid tumor with a unique long-term survival.
Fabre A; Eyden B; Ali HH
Ultrastruct Pathol; 2004; 28(1):49-52. PubMed ID: 14967599
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of cytopathologic features of epithelioid sarcoma in a series of 7 uncommon cases with immunohistochemical results, including loss of INI1/SMARCB1 in two test cases.
Rekhi B; Singh N
Diagn Cytopathol; 2016 Jul; 44(7):636-42. PubMed ID: 27145123
[TBL] [Abstract][Full Text] [Related]
11. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
[TBL] [Abstract][Full Text] [Related]
12. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence.
Itakura E; Tamiya S; Morita K; Shiratsuchi H; Kinoshita Y; Oshiro Y; Oda Y; Ohta S; Furue M; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):854-61. PubMed ID: 11557780
[TBL] [Abstract][Full Text] [Related]
14. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
Hornick JL; Dal Cin P; Fletcher CD
Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
[TBL] [Abstract][Full Text] [Related]
15. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.
Fanburg-Smith JC; Hengge M; Hengge UR; Smith JS; Miettinen M
Ann Diagn Pathol; 1998 Dec; 2(6):351-62. PubMed ID: 9930572
[TBL] [Abstract][Full Text] [Related]
16. Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?
Terada T
Int J Clin Exp Pathol; 2013; 6(4):724-8. PubMed ID: 23573320
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
[TBL] [Abstract][Full Text] [Related]
18. Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior.
Oshiro Y; Shiratsuchi H; Oda Y; Toyoshima S; Tsuneyoshi M
Mod Pathol; 2000 Nov; 13(11):1211-8. PubMed ID: 11106079
[TBL] [Abstract][Full Text] [Related]
19. Proximal-type epithelioid sarcoma of the vulva: relationship to malignant extrarenal rhabdoid tumor.
Tholpady A; Lonergan CL; Wick MR
Int J Gynecol Pathol; 2010 Nov; 29(6):600-4. PubMed ID: 20881848
[TBL] [Abstract][Full Text] [Related]
20. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
